US Stock MarketDetailed Quotes

CALT Calliditas Therapeutics

Watchlist
  • 20.540
  • +0.210+1.03%
Close May 10 16:00 ET
611.88MMarket Cap-12821P/E (TTM)

Calliditas Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Calliditas Therapeutics Earnings Date

Currency: SEK

Period

Q1 FY2024 Earnings Estimates

May 23, 2024

Revenue(YoY)

382.77M

+100.03%
EPS(YoY)

-1.10

+84.26%
Analyst Rating

Strong Buy

May 11, 2024

Calliditas Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: SEK

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 7, 20242024/Q2-- / 426.466M--
May 23, 20242024/Q1-- / 382.765M--
Feb 21, 20242023/Q4451.561M / 386.482M--
Nov 7, 20232023/Q3294.592M / 330.581M--
Aug 17, 20232023/Q2269.384M / 285.868M--
--2023/Q1191.352M / 231.985M--
Feb 23, 20232022/Q4429.042M / 204.047M--
Nov 14, 20222022/Q3260.056M / 137.022M--
Aug 18, 20222022/Q264.000M / 78.271M--
May 18, 20222022/Q149.734M / 49.174M--
DatePeriodRevenue/EstimateEarnings Call
Aug 7, 20242024/Q2-- / 426.466M--
May 23, 20242024/Q1-- / 382.765M--
Feb 21, 20242023/Q4451.561M / 386.482M--
Nov 7, 20232023/Q3294.592M / 330.581M--
Aug 17, 20232023/Q2269.384M / 285.868M--
--2023/Q1191.352M / 231.985M--
Feb 23, 20232022/Q4429.042M / 204.047M--
Nov 14, 20222022/Q3260.056M / 137.022M--
Aug 18, 20222022/Q264.000M / 78.271M--
May 18, 20222022/Q149.734M / 49.174M--

Unlock Free Earnings Estimates

Calliditas Therapeutics Earnings Reports

  • Calliditas Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 26 04:11

  • Calliditas Therapeutics | 20-F: Registration statement / Annual report / Transition report

    Apr 25 10:20

  • Calliditas Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Feb 22 05:09

  • Calliditas Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Jan 8 13:00

    • Read more

    Analysis

    Analyst Rating

    Updated: May 11, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg